In this work, the role of HDAC6, a type II histone deacetylase with tubulin deacetylase activity, in lymphocyte polarity, motility, and transmigration was explored. HDAC6 was localized at dynamic subcellular structures as leading lamellipodia and the uropod in migrating T-cells. However, HDAC6 activity did not appear to be involved in the polarity of migrating lymphocytes. Overexpression of HDAC6 in freshly isolated lymphocytes and T-cell lines increased the lymphocyte migration mediated by chemokines and their transendothelial migration under shear flow. Accordingly, the knockdown of HDAC6 expression in T-cells diminished their chemotactic capability. Additional experiments with HDAC6 inhibitors (trichostatin, tubacin), other structural related molecules (niltubacin, MAZ-1391), and HDAC6 dead mutants showed that the deacetylase activity of HDAC6 was not involved in the modulatory effect of this molecule on cell migration. Our results indicate that HDAC6 has an important role in the chemotaxis of T-lymphocytes, which is independent of its tubulin deacetylase activity.
INTRODUCTION
Lymphocyte migration is essential for the activity of the immune system in physiological conditions and during adaptive immune responses. Lymphocyte chemotaxis requires the coordinated activity of adhesion and chemotactic receptors, signaling molecules, and cytoskeleton (VicenteManzanares and Sanchez-Madrid, 2004) . Chemokines are a family of low-molecular-weight cytokines that bind to G protein-coupled receptors on the cell surface (Mackay, 2001) . In addition to their classical function as chemoattractants, chemokines modulate lymphocyte adhesion to endothelium, through a yet-poorly understood mechanism of receptor cross-talk between chemotactic and adhesion receptors (Alon and Feigelson, 2002; von Andrian and Mackay, 2000) . Chemokines also trigger the remodeling of cytoskeleton and the reorganization of multiple plasma membrane receptors and signaling molecules, which result in an overall change of lymphocyte shape and the acquisition of a migratory, polarized morphology (Sanchez-Madrid and del Pozo, 1999) . Lymphocyte polarization involves the generation of two well-differentiated poles. The leading edge clusters actin microfilaments, actin-associated proteins, and signaling molecules that generate protrusive structures, and concentrates adhesion receptors at the cell front. On the other hand, adhesions are released at the rear trailing edge to enable net cell movement (Serrador et al., 1999; Worthylake and Burridge, 2001; Etienne-Manneville and Hall, 2002; Ridley et al., 2003; Vicente-Manzanares and Sanchez-Madrid, 2004) .
Although there is much knowledge on how the actin cytoskeleton participates in cell migration (Pantaloni et al., 2001; Pollard and Borisy, 2003) , the role played by tubulin and associated proteins in this process remains controversial and seems cell type-dependent (Wittmann and WatermanStorer, 2001; Destaing et al., 2005) . However, it is clear that, in addition to their role during cell division, microtubules play important functions in the establishment and maintenance of cell polarity and adhesion (Prescott et al., 1989; Tannenbaum and Slepecky, 1997; Moreno and Schatten, 2000; Small and Kaverina, 2003) . The majority of interphase microtubules are dynamic, but a small proportion is relatively stable (Schulze and Kirschner, 1987) , showing a low rate of depolymerization by colchicine or cold. Microtubule stability is related to post-translational modifications of tubulin subunits (Gundersen et al., 1998) , including the acetylation of the Lys40 -amino group of ␣-tubulin (L' Hernault and Rosenbaum, 1983; Piperno and Fuller, 1985) . This type of acetylation has been found in a variety of proteins (transcription and nuclear import factors, histones) and is catalyzed by a wide range of acetyltransferases (Kouzarides, 2000; Polevoda and Sherman, 2002) . In cultured cells, acetylation seems to preferentially occur in polymerized microtubules (Piperno et al., 1987) . It has been shown that in vivo, deacetylation takes place on tubulin dimers, rather than microtubules (Matsuyama et al., 2002) .
HDAC6, a class II histone deacetylase mainly localized in the cytoplasm (Verdel et al., 2000; Bertos et al., 2004) , has two catalytic domains with deacetylase activity. The C-terminal domain is able to deacetylate ␣-tubulin both in vitro and in vivo, and this activity is reversibly inhibited by trichostatin A (TSA) and tubacin. TSA is a broad HDACs inhibitor, whereas tubacin is specific for the tubulin deacetylase activity of HDAC6 (Hubbert et al., 2002; Matsuyama et al., 2002; Haggarty et al., 2003; Zhang et al., 2003) . These compounds inhibit the HDAC6 deacetylase activity by chelating a Zn 2ϩ cation (Furumai et al., 2001; Jose et al., 2004) and may also alter the formation of dynamic molecular complexes of HDAC6 with other intracellular proteins such PP1, HSP90, Dia2, dynein, or tubulin (Kawaguchi et al., 2003; Brush et al., 2004; Destaing et al., 2005; Hideshima et al., 2005; Kovacs et al., 2005) . In this regard, it has been reported that TSA disrupts HDAC6/PP1 association, affecting the enzymatic activity of both molecules (Brush et al., 2004) .
We have herein investigated the role of HDAC6 in the migration of T-lymphocytes. We found that HDAC6 is mainly concentrated at cellular regions with high protrusive activity in migrating lymphocytes and that its expression modulates lymphocyte chemotaxis independently of its enzymatic activity.
MATERIALS AND METHODS

Reagents and Antibodies
Trichostatin A (TSA), nocodazole (NCD), and paclitaxel (Taxol; TXL) were purchased from Calbiochem (San Diego, CA). SDF-1␣ was from R&D Systems (Minneapolis, MN), and sodium butyrate from Sigma Chemical Co. (St. Louis, MO). Tubacin, DHM-tubacin, niltubacin, MAZ-1391, MAZ-1338, and MAZ-1380 were synthesized according to Mazitschek et al. (unpublished data) . The 80-kDa fibronectin fragment (FN80) was a generous gift from Dr. A. García-Pardo (Centro de Investigaciones Bioló gicas, Madrid, Spain). Phytohemaglutinin A (PHA) and interleukin-2 (IL-2) were from Sigma. Rabbit and goat anti-human HDAC6 polyclonal antibodies were purchased from MBL (Watertown, MA) and Santa Cruz Biotechnology (Santa Cruz, CA), respectively. The anti-␣-tubulin B-5-1-2 monoclonal antibody (mAb), the FITCconjugated anti-␣-tubulin (clone DM1A), and the anti-acetylated ␣-tubulin 6 -11B-1 mAbs were purchased from Sigma. The JL-8 anti-GFP mAb was from BD Biosciences Clontech (Palo Alto, CA). For surface molecule staining, the following mAbs were used: HP2/19 anti-ICAM-3, 12G5 anti CXCR4, MAB181 anti-CCR5, PL-1 anti-PSGL-1, anti-CD62L, Lia3/2 anti-CD18, HP2/21 anti-CD43 and HUTS-21 anti-activated ␤1 integrins.
Cells
Human T-cell lines HSB-2 and CEM 1.3 were grown in RPMI 1640 culture medium (Invitrogen, Gaithersburg, MD) supplemented with 10% fetal calf serum (FCS). Human peripheral blood lymphocytes (PBLs) were obtained as described by Campanero et al. (1994) , and T lymphoblasts by 48-h treatment with 1 g/ml PHA, followed by 50 U/ml IL-2 in RPMI 1640 medium until the eleventh day.
Transfection of Cells and Recombinant DNA Constructs
PBLs were washed once in phosphate-buffered saline and resuspended (1.2 ϫ 10 7 cells/ml) in electroporation buffer containing 12 g of plasmid DNA pEGFP, wtHDAC6-EGFP or double mutant HDAC6 H216A/H611A-EGFP (HDAC6 DD). Cell suspensions (100 L) were transferred to a 2.0-mm elec- troporation cuvette and nucleofected with an Amaxa Nucleofector apparatus (Amaxa GmbH, Cologne, Germany). Then, cells were transferred to complete medium without antibiotic and cultured in six-well plates at 37°C until analysis. HSB-2 cells were transfected by electroporation. The human T-cell line CEM 1.3 was transduced with the retroviral vector pLZR IRES to stably express EGFP, wtHDAC6-EGFP, or HDAC6 H216A/H611A-EGFP. Retroviruses were produced by transfection of the Phoenix packaging cell line with a DNA mixture containing 2.5 g env (pVSV-G; Clontech, BD Biosciences), 4 g gag-pol (pNGVL3-MLV) and 3.5 g retroviral vector pLZR IRES (a generous gift from Dr. A. Bernad, Centro Nacional de Biotecnología, Cantoblanco, Madrid, Spain). Supernatant with retroviruses was recovered and filtered 48 h after transfection and diluted 1:2 in RPMI 1640 medium. The infection was carried out by spinning 5.0 ϫ 10 5 CEM cells, with 200 l of retroviral supernatant and polybrene at 6 g/ml, per well (24-well plates, Costar, Corning, NY), at 1800 rpm, 30°C for 90 min. Finally, 300 l of complete RPMI medium was added, and cells were cultured at 37°C in 5% CO 2 atmosphere.
siRNA Assay
Double-stranded siRNA (21 pb) against the HDAC6 217-237 (Hubbert et al., 2002; Serrador et al., 2004) and 284 -304 sequences, and the negative control was purchased from Eurogentec (Hampshire, United Kingdom). PBL cells (7.0 ϫ 10 6 ) were nucleofected with the siRNA using the Human T-Cell nucleofector kit (Amaxa GmbH). Efficiency was assessed by Western blot.
Immunofluorescence Microscopy
These assays were performed as described (Serrador et al., 2004) . Briefly, 5.0 ϫ 10 5 cells were allowed to adhere to coverslips coated with FN80. When indicated, cells were pretreated or not with SDF-1␣, TSA, TSAϩSDF-1␣, NCD, TXL, or sodium butyrate. Cells were then fixed and stained for acetylated and total ␣-tubulin using the 6-11B-1 and DM1A antibodies. Endogenous HDAC6 was stained with the goat anti-HDAC6 antibody and a secondary donkey anti-goat Alexa-488 -conjugated antibody. Cells were observed in a Leica DMR photomicroscope (Leica, Mannheim, Germany), and images were visualized, processed, and stored by using the Leica QFISH software.
Time-Lapse Fluorescence Confocal Microscopy
PBL or CEM cells (5 ϫ 10 5 ) were allowed to adhere on FN-coated coverslips, maintained in 1 ml of 2% BSA Hanks' balanced salt solution (HBSS) on Attofluor open chambers (Molecular Probes, Eugene, OR), and placed on the microscope stage. Cells were maintained at 37°C in a 5% CO 2 atmosphere. Series of fluorescence and differential interference contrast frames were ob- (C) HDAC6-GFP-transfected PBLs incubated with the indicated stimuli and adhered to 50 g/ml FN were fixed, permeabilized, and stained for acetylated tubulin. Arrows pointed to leading edge and the asterisk stands on the rear pole in the SDF-1␣-polarized PBLs. (D) Time-lapse sequence of HDAC6-GFPexpressing PBLs transfected by nucleofection. Cells were allowed to adhere to FN and stimulated with 100 ng/ml SDF-1␣ at time zero. Then, cells were analyzed for 7 min by time-lapse confocal microscopy, as stated in Materials and Methods. Arrows pointed to the leading edge in the SDF-1␣-polarized migrating PBLs.
tained simultaneously, using a Leica TCS SP confocal laser scanning unit attached to a Leica DMIRBE inverted epifluorescence microscope.
Chemotaxis Assay in Transwell Chambers
Assays for lymphocyte chemotaxis were performed in nude or TNF-␣-activated human umbilical vein endothelial cells (HUVEC)-coated polycarbonate membranes of 6.5-mm diameter, 10-m thickness, and 3-or 5-m-diameter pore size Transwell chambers (Costar). Lymphocytes (100 l at 1.0 ϫ 10 6 cells/ml) resuspended in 0.5% human serum albumin RPMI 1640 were added to the upper chamber. Then, chemokines (100 ng/ml SDF-1␣) were added to the lower chamber, and cells were allowed to migrate for 2 h at 37°C in 5% CO 2 atmosphere. Then, the migrated cells were recovered and counted by flow cytometry.
Transendothelial Migration under Flow Conditions
The parallel plate flow chamber used for leukocyte adhesion and transmigration under defined laminar flow has been described (Barreiro et al., 2002) . PBL or CEM T-cells (10 6 /ml) were drawn on a TNF-␣-activated confluent endothelial monolayer at an estimated wall shear stress of 1.8 dyn/cm 2 for a total perfusion time of 10 min. Lymphocyte rolling on the endothelium was easily visualized because they traveled more slowly than free-flowing cells. Lymphocytes were considered to be adherent after 20 s of stable contact with the cell monolayer. Transmigrated lymphocytes were determined as being beneath the endothelial monolayer. Lymphocytes were considered detached when they returned to free-flowing after their complete arrest on endothelium. The number of rolling, adhered, transmigrated, and detached cells was quantified by direct visualization of eight different fields (20ϫ phase-contrast objective) at each time point of every independent experiment.
For detachment experiments, PBLs untreated or pretreated with TSA or sodium butyrate for 1 h were allowed to adhere for 4 min at 37°C to activated HUVEC monolayers. Then, shear stress was applied by pulling assay buffer (HBSS buffer with 2% FCS) through the flow chamber with a calibrated programmable pump, starting at 0.5 dyn/cm 2 and increasing up to 10 dyn/ cm 2 at 1-min intervals. Attached and transmigrated cells after each shear stress interval were quantified (20ϫ phase-contrast objective), and the mean Ϯ SD of seven fields is presented. Cell detachment was obtained from the difference of final to initial adhered plus transmigrated cells (Barreiro et al., 2005) .
Western Blot Analysis
Cell lysates were subjected to 10% SDS-PAGE under reducing conditions, and transferred onto nitrocellulose membranes (Trans-Blot, Bio-Rad, Hercules, CA). Then, membranes were saturated with tris-buffered saline-0.1% Tween containing 3% BSA and incubated with mAb against ␣-tubulin or acetylated- ␣-tubulin or HDAC6 or GFP, followed by a peroxidase-conjugated secondary antibody. Proteins were visualized by enhanced chemiluminescence, and densitometric analyses were performed with ImageGauge 3.46 software (Fuji Photo Film Co., Tokyo, Japan).
Tubacin-niltubacin competition assays were carried out for 120 min at 37°C and 5% CO 2 in CEM leukemic T-cells and PBLs. Tubacin (0.25 or 0.5 M) was coincubated with at least eight different concentrations, from 1 nM to10 M, of niltubacin to determine IC 50 (concentration [M] of this competing ligand that inhibits by 50% the effect of tubacin binding). Western blotting of acetylated tubulin resulting from the competitive effect of niltubacin versus tubacin for HDAC6 was then performed. Data were analyzed using GraphPad Prism 2.0 software (GraphPad Software, San Diego, CA).
RESULTS
HDAC6 Is Concentrated in Motile Structures of Polarized Migrating Lymphocytes
To explore the role of HDAC6 in lymphocyte polarity, we first determined the possible relationship between the levels of acetylated tubulin and the polarized shape of T-cells. As expected, we found an increase in total tubulin in PBLs activated with PHA and cultured with IL-2 that peaked between days 4 and 8 ( Figure 1A, bottom panel) . However, the increase in the levels of acetylated tubulin reached maximal levels at day 8 of cell culture ( Figure 1A, top, and B) . Acetylated microtubules were preferentially organized in bundles around the microtubule-organizing center (MTOC) within the cellular uropod ( Figure 1B) . Likewise, HSB-2 T-cells, which exhibit a constitutively polarized morphology (Serrador et al., 1997) , also displayed significant amounts of acetylated ␣-tubulin concentrated at their uropods ( Figure 1B) .
We then assessed the subcellular localization of HDAC6 in polarized migrating lymphocytes. Immunofluorescence experiments showed that HDAC6 was mainly concentrated at the front lamellipodium of polarized cells and evenly distributed in resting PBLs (Figure 2A ). On the other hand, in HSB-2 cells or PBLs transfected with either flag-or GFPtagged HDAC6, this enzyme was concentrated at the uropod and the leading edge (Figure 2, B-D) . This localization was maintained when cells were treated with TSA or sodium butyrate, a HDACs inhibitor that lacks activity on HDAC6 (Serrador et al., 2004) .
The effect of HDAC6 overexpression on microtubule acetylation was also studied. Tubulin acetylation levels were reduced in cells overexpressing HDAC6 (Figure 2 , B and C), an effect that was inhibited by TSA (Figure 2, B and C) . In TSAtreated cells, HDAC6 colocalized with acetylated microtubules (Figure 2, B and C) . Chemokines have been reported as main inducers of lymphocyte polarity (del Pozo et al., 1995) . When TSA-treated PBLs were induced to polarize with SDF-1␣, they acquired a polarized migratory morphology, and HDAC6 was redistributed to the leading edge and the uropod (Figure 2 , C and D). Live-cell time-lapse confocal videomicroscopy confirmed the localization of HDAC6 at motility-associated structures in PBLs transfected with HDAC6-GFP and stimulated with SDF-1␣ ( Figure 2D and sal material, Supplementary Video 1).
Lymphocyte Transmigration Inhibition by HDAC6
Inhibitor TSA We then investigated the role of HDAC6 in lymphocyte migration. Pretreatment of PBLs with TSA for 1 h (to avoid its effect on gene transcription) decreased lymphocyte chemotaxis and their transendothelial migration ( Figure 3A , and B). Similar results were observed in HSB-2 and CEM T-cells (unpublished data). The inhibitory effect of TSA was more evident when lymphocytes were allowed to transmigrate across the endothelial cell monolayer. On the other hand, treatment of lymphocytes with TXL decreased cell migration, whereas NCD had an opposing effect ( Figure 3B ). Additional experiments showed that TSA did not have a significant effect on T-cell adhesion or the expression of chemokine and adhesion receptors (Figure 3 , C and D, and Table 1A ).
The role of HDAC6 activity in T-cell migration was also analyzed under flow conditions. Although butyrate did not significantly affect any step of lymphocyte transendothelial migration, TSA-treated cells showed a reduced adhesion to the activated endothelium under shear stress, and the detachment rate was significantly higher compared with untreated or butyrate-treated cells ( Figure 3E ). Furthermore, cell detachment assays at increasing shear flow showed that the binding strength of either untreated or butyrate-treated PBLs adhered to activated endothelial cells was higher than that of TSAtreated PBLs ( Figure 3F ). These findings indicate that TSA negatively affects lymphocyte extravasation, mainly their firm adhesion to endothelium under flow stress conditions, an effect that is not evident under static conditions. This could be due to blockage of deacetylase activity and/or disruption of HDAC6 molecular complexes by TSA (Brush et al., 2004) .
Deacetylase Activity of HDAC6 Is Not Involved in Lymphocyte Migration
To further explore the role of HDAC6 enzymatic activity in lymphocyte migration, we used tubacin (a specific HDAC6 tubulin deacetylase inhibitor), and other deacetylase inactive tubacin derivatives (niltubacin, MAZ-1391, MAZ-1338, and MAZ-TBDPS-O-1380) (Figure 4, A and B) . Tubacin inhibits HDAC6 tubulin deacetylase activity in a dose-dependent manner, reaching a plateau at 10 -20 M, whereas niltubacin did not exert any effect at the same doses ( Figure  4B and unpublished data). Tubacin inhibited the chemotaxis of PBLs, HSB-2, and CEM T-cells induced by SDF-1␣ ( Figure  4C and unpublished data). Unexpectedly, the inactive compounds niltubacin, MAZ-1338, and MAZ-1391 also decreased cell migration ( Figure 4C ). In contrast, the inactive derivative MAZ-TBDPS-O-1380 did not exert this effect (Figure 4C ). Neither tubacin nor niltubacin affected the adhesion of PBLs or T-cells to FN-80 in static conditions ( Figure 4D ). Likewise, no significant changes on cell viability and the expression levels of different adhesion and chemokine receptors were detected when CEM cells were treated with tubacin or niltubacin (Table 1B and unpublished data). To further ascertain whether niltubacin was exerting its effects by binding to the same and/or overlapping site(s) as tubacin on the HDAC6 molecule, cross-competitive tubulin deacetylase functional assays were performed. Niltubacin prevented the inhibitory effect of tubulin deacetylase caused by tubacin, in a dose-dependent manner ( Figure 5 , A-C), thus indicating both molecules were interacting with the same and/or overlapping site(s) of the HDAC6 molecule. In parallel, migration assays showed that the combination of tubacin (0.5 M) with increasing doses of niltubacin, which revert the tubacin-deacetylase inhibitory effect, resulted in a similar inhibition level of lymphocyte migration compared with same doses of tubacin alone ( Figure 5D ). Therefore, although tubacin is an active specific inhibitor of HDAC6 tubulin deacetylase, its effect on lymphocyte migration seems to be exerted independently of its inhibitory effect upon deacetylase enzymatic activity. Moreover, in T-lymphocyte polarization induced by the chemokine SDF-1␣, similar results were observed in cells treated with TSA, tubacin or niltubacin, which suggest that HDAC6 tubulin deacetylase activity is neither essential for lymphocyte polarization (Figures 2 and 6 ) nor migration ( Figures 4C and 5) .
Overexpression of HDAC6 and the Deacetylase Dead Mutant Enhances T-Lymphocyte Migration
The effect of HDAC6 on lymphocyte migration was also analyzed. CEM T-cells were transduced and PBLs were nucleofected to overexpress wtHDAC6-GFP or HDAC6 H216A/H611A-GFP ( Figure 7 , A and B, and 8A, respectively). We found that overexpression of wtHDAC6 or deacetylase dead mutant in CEM leukemic T-cells ( Figure  7B ) and PBLs ( Figure 8A ) exhibited enhanced transmigration when compared with GFP-alone overexpressing cells. Interestingly, migratory CEM cells overexpressing either HDAC6-GFP or HDAC6 H216A/H611A-GFP showed an accumulation of this enzyme at the cell leading edge and, in lesser extent, in the uropod ( Figure 7C , Supplementary Videos 2 and 3, and unpublished data). In addition, the overexpression of HDAC6-GFP favored the adhesion and transmigration of CEM cells under flow conditions, whereas the rolling and detachment steps were proportionally significantly diminished ( Figure 7D) . Furthermore, the number of leukocyte-endothelium interactions was dramatically increased in the HDAC6-GFP-transduced cells (absolute values: 574 for pLZR-HDAC6 vs. 258 for pLZR-GFP or 327 for untransduced parental cells). These data concur with those obtained using the chemical HDAC6 inhibitor (Figure 3E ). In conclusion, overexpression of both HDAC6 and the deacetylase dead mutant, which localizes at motility-related structures, enhances lymphocyte migration. Therefore, deacetylase activity appears to be dispensable for HDAC6-regulated chemotaxis.
Knocking Down of HDAC6 Inhibits Lymphocyte Chemotaxis
The effect of HDAC6 on lymphocyte chemotaxis was also analyzed by knocking down expression. We found that siRNA-HDAC6-interfered PBL and CEM cells showed a diminished expression of HDAC6 and a defective migratory activity in response to the chemokine SDF-1␣ (Figure 8 , B-D). To unequivocally demonstrate that HDAC6 molecule itself was accounting for the above-described functional effects, HDAC6wt, and catalytically inactive HDAC6DD were compared in restoring the migration of HDAC6-interfered cells. The results convincingly show that defective cell migration is reverted at comparable level by overexpression of both HDAC6wt and HDAC6DD molecules ( Figure 8C ) and that the effect is HDAC6 specific. Moreover, adhesion and transmigration of HDAC6 knockdown CEM cells to activated HUVEC was assessed under shear stress conditions. As observed above for TSA-treated lymphocytes (Figure 3, E  and F) , a reduced number of adherent and transmigrated 6 . TSA, tubacin, and niltubacin do not modify the polarization of PBL induced by SDF-1. PBL were treated as indicated and then allowed to adhere to FN-coated coverslips for 15 min. Cells were then fixed and stained with an anti-ICAM-3 mAb followed by an FITC-labeled secondary antibody. Cell polarization was determined as stated in Materials and Methods. The arithmetic mean Ϯ SD of three independent experiments is shown.
lymphocytes was found in HDAC6-knockdown cells ( Figure  8D ). These data show that the overexpression of HDAC6 enhances lymphocyte migration, whereas its targeting inhibits lymphocyte chemotaxis. 
DISCUSSION
Although the roles of tubulin cytoskeleton and microtubule acetylation in the migration of adherent cells have been studied (Joseph et al., 1989; Terzis et al., 1997; Westerlund et al., 1997; Hubbert et al., 2002; Haggarty et al., 2003) , little is known regarding its involvement in the motility of leukocytes. In this work, we have addressed the possible role of HDAC6 tubulin deacetylase in the migratory activity of T-lymphocytes. We have found that activated T-cells show increased levels of acetylated microtubules around the MTOC, partially colocalizing with HDAC6. It has been reported that the microtubular network is retracted toward the uropod in T-cells polarized by chemokines (Ratner et al., 1997) . On the other hand, we and others have previously shown that microtubules do not play an important role in uropod formation (Wilkinson, 1986; Campanero et al., 1994; Brown et al., 2001) . Whether the enhanced levels of acetylated microtubules seen in polarized migrating T-lymphocytes are part of the mechanism by which microtubular bundles are retracted into the uropod or occur after retraction of the microtubule meshwork into this structure is still an open question. However, our data using different chemical inhibitors of HDAC6 and experiments with cells overexpressing HDAC6 deacetylase dead mutant do not support a role for tubulin deacetylase activity in the acquisition of a polarized migratory cell shape.
Our data on the localization of HDAC6 at motile protrusive structures, such as the leading edge and the uropod, support a possible involvement of this molecule in the regulation of lymphocyte locomotion. Accordingly, we found that the migration of T-cells in response to chemokines is reduced by HDAC6 siRNA and increased by HDAC6 overexpression and that these effects are not due to changes in cell adhesiveness under static conditions. Nevertheless, our data under shear stress conditions clearly indicate that adhesion strength is weaker in lymphocytes in which HDAC6 has been targeted by either a chemical inhibitor or specific siRNA knockdown. Hence, HDAC6 molecules appear to be required for adhesion and transmigration of lymphocytes under mechanical stress conditions or when cells transmigrate across constricted spaces. These data, together with similar results in mouse NIH3T3 fibroblasts (Hubbert et al., 2002) , suggest that HDAC6 levels modify molecular interactions or intracellular signaling pathways involved in the modulation of cell motility. Interestingly, we have found that the levels of HDAC6 but not its deacetylase activity seems to be critical for lymphocyte chemotaxis. Hence, our data with a panel of tubacin derivatives, together with the results with cells overexpressing wt and deacetylase inactive forms of HDAC6, underscore the critical role of this molecule in lymphocyte motility regardless of its enzymatic activity. This is apparently in disagreement with data obtained in NIH3T3 fibroblasts, in which HDAC6 deacetylase activity was related to cell motility (Hubbert et al., 2002; Haggarty et al., 2003; Palazzo et al., 2003) . However, it is feasible that HDAC6 has a scaffold role for the rapid formation of molecular complexes required for lymphocyte migration, a process 10-to 20-fold faster than that of fibroblasts (Serrador et al., 1999) . Hence, very dynamic processes such as leukocyte locomotion would require a rapid HDAC6-mediated on/off assembly of molecular complexes, whereas this effect of HDAC6 would be dispensable in slow dynamic processes such as fibroblast locomotion or other phenomena involving cell-to-cell immune or viral-mediated interactions (Serrador et al., 2004; Valenzuela-Fernandez et al., 2005) .
Little is known about the signal transduction pathways controlling HDAC6 activity. It has been recently described that HDAC6 forms complexes with phosphatases, including the catalytic subunit of PP1, and that HDAC6-PP1 interaction is disrupted by TSA (Brush et al., 2004; Chen et al., 2005) . In addition, we have previously reported that tubulin acetylation diminishes in lymphocytes when the activity of RhoA is abolished (Vicente-Manzanares et al., 2002) . Furthermore, it is known that Rho GTPases coordinate the two poles of migrating T-lymphocytes (Sanchez-Madrid and del Pozo, 1999; Worthylake and Burridge, 2001 ) and control the dynamics of actin and tubulin cytoskeleton (Wittmann and Waterman-Storer, 2001; Ridley et al., 2003) . It is therefore feasible that HDAC6 has a role in the cross-talk between tubulin-and actin-associated molecules. This role of HDAC6 might explain the relationship between chemokines, Rho/ mDia activation/inactivation (Vicente-Manzanares et al., 2002; Palazzo et al., 2004; Destaing et al., 2005) and the consequences of targeting HDAC6 on cell migration (Hubbert et al., 2002; Haggarty et al., 2003; and this report) . Whether Rho GTPases could regulate the activity of HDAC6 and its interaction with motor proteins is an interesting point to be explored. We propose that mechanisms such as alteration in signaling or relative PP1, HSP90, mDia, dynein, or tubulin dissociation from molecular complexes with HDAC6 (Kawaguchi et al., 2003; Brush et al., 2004; Bali et al., 2005; Destaing et al., 2005; Hideshima et al., 2005; Kovacs et al., 2005) could modulate lymphocyte migration independently of its deacetylase activity.
